NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Spark Biomedical Inc

Spark Biomedical Inc

Private
Dallas, TexasHealthcare & Life Scienceshttps://sparkbiomedical.com/

Last Round

Early Funding

Mar 2, 2026

Total Funding Raised

$21.01M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Spark Biomedical Inc is a medical device company that develops wearable neurostimulation solutions for opioid withdrawal, mental health, women's health, and hemostasis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Mental Health

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Application

Keywords

transcutaneous auricular neurostimulationtANneuromodulationopioid withdrawal treatmentnon-invasive neurostimulationmedical devicewearable medical devicebioelectronic medicineaddiction treatment technologyclosed-loop therapywomen's health technologydigital therapeuticsnon-narcotic pain managementclinical research platformmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spark Biomedical Inc Comparables

Compare Spark Biomedical Inc with similar companies based on industry and business-model similarity.

Spark Biomedical Inc comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NET Recovery Corp.
89%
DyAnsys, Inc.
88%
Masimo Corporation
79%

Spark Biomedical Inc Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMar 2, 2026
GrantOct 20, 2025
GrantAug 19, 2025
Series AApr 29, 2025
GrantFeb 20, 2025
Grant
Sep 12, 2024

Key People

Founding team and executive leadership

Navid Khodaparast

Co-founder Chief Science Officer

Founding Team

Daniel Powell

CEO

Executive Team

Alejandro Covalin

Chief Technology Officer

Executive Team

Karl Pawlik

CFO

Executive Team

Spark Biomedical Inc Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 10, 2026

    Launched Phase II LUNA Trial for neurostimulation technology.

  • Feb 16, 2026

    $500K raised in a grant round.

Spark Biomedical Inc Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Spark Biomedical Inc Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Spark Biomedical Inc's valuation, stock price, and market status.

Firmographic Details

HeadquartersDallas, Texas
Employee Range26
Year Founded2018
Last FundingMar 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.